U.S. Health Care Finance: Costs, Access, and Global Comparisons
This paper critically examines the financing and structure of the U.S. health care system in comparison to other industrialized nations. Drawing on Greenwald's analysis, the paper identifies methodological concerns with cherry-picked international comparisons while exploring why the United States has historically resisted universal health care. The discussion considers social, economic, and racial factors that shape access disparities, noting that high-quality care in the U.S. is available primarily to those who can afford it. The paper also examines why health care costs are lower in other nations and how investment in advanced medical equipment, while improving quality at the top end, contributes to higher overall expenditures in the American system.
- Introduction: Comparing Health Care Systems: Critiques Greenwald's cherry-picked international comparisons
- Universal Care vs. Quality of Care: Trade-offs between universal access and care quality
- Social and Economic Roots of U.S. Health Care Gaps: Economic and racial factors behind uninsured rates
- Health Care Costs in the United States: Why U.S. costs exceed other nations
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper demonstrates critical engagement with a source text, identifying Greenwald's methodological weakness — cherry-picking international comparisons — rather than accepting his conclusions uncritically.
- It grounds structural health care arguments in social and historical context, connecting racial inequality, deindustrialization, and political culture to the absence of universal coverage in the U.S.
- The writing moves fluidly between critique of a specific author and broader analytical claims, showing how to build an independent argument from a reviewed source.
Key academic technique demonstrated
The paper models source-critical analysis: it engages a secondary source (Greenwald) substantively, concedes valid points, and then identifies where the argument is incomplete or misleading. This technique — acknowledging merit before pivoting to critique — is a hallmark of strong academic argumentation.
Structure breakdown
The paper opens with a methodological critique of Greenwald's comparative approach, then transitions to the broader debate over universal versus high-quality care. It grounds that debate in U.S.-specific social history before turning to a cost analysis. The paper is cut short before the cost section concludes, suggesting it is a partial excerpt. Each section builds logically on the previous one, moving from methodological concerns to systemic explanations.
Introduction: Comparing Health Care Systems
Greenwald engages in a discussion comparing the U.S. health care system to other health care systems around the world. An interesting methodological fault, however, is that Greenwald cherry-picks his examples. In one paragraph he compares the U.S. with Canada, in another the UK, and in another Spain. The methodological problem is that he can select data from whichever country best suits his argument at any given moment. What this means, in terms of interpretation, is that Greenwald's findings need to be taken with a grain of salt.
As one example, Greenwald notes higher wait times in three countries for urgent coronary artery bypass surgery. Nobody likes high wait times, but Greenwald's U.S. figure does not factor in the uninsured, whose effective wait time is infinite — they simply go without care. The issue many people have with the U.S. system is not that performance is poor; it is that high performance is only available to those who can afford it.
Universal Care vs. Quality of Care
This distinction cuts to the heart of the difference between the U.S. and other industrialized countries. A trade-off between quality of care and universality of care exists in any nation. The trade-off other countries have made is to choose universal coverage, even when service standards are sometimes lower. In the United States, there has never been a strong collective motivation to make that same trade-off.
The reasons for this are more social than medical. While some have argued that lobbyists are the primary obstacle, that assessment is difficult to sustain, because most other nations adopted universal health care long before lobbying came to dominate U.S. policymaking. The absence of universal health care in the U.S. is therefore more closely related to social factors.
Create your account
Always verify citation format against your institution’s current style guide requirements.